Company Update2 Min Read InvestyWise NewsonNovember 6, 2025 Angel One Strong Client Growth and Order Volume in October 2025 Angel One reported strong business performance for October 2025, with client base reaching 34.57 million, a 22.5% year-over-year growth.…
Board Meeting1 Min Read InvestyWise NewsonNovember 5, 2025 Lemon Tree Hotels Board to Consider Unaudited Financial Results for Q2 & H1 2026 Lemon Tree Hotels has announced that its Board of Directors will meet on November 12, 2025, to consider and approve the unaudited financial…
Company Update1 Min Read InvestyWise NewsonNovember 5, 2025 Maharashtra Seamless Audio Recording of Q2 FY26 Earnings Conference Call Maharashtra Seamless has announced the availability of the audio recording of its conference call pertaining to the earnings for the second…
Company Update1 Min Read InvestyWise NewsonNovember 5, 2025 Motherson Penalty Order Received Regarding GST on Corporate Guarantees Motherson has received a penalty order related to non-payment of Goods & Service Tax (GST) on guarantee commission disclosed in…
Company Update2 Min Read InvestyWise NewsonNovember 5, 2025 Godrej Agrovet Reports Q2 & H1 FY26 Financial Results Godrej Agrovet Limited (GAVL) announced its financial results for the second quarter (Q2) and half-year (H1) ended September 30, 2025. The…
Company Update1 Min Read InvestyWise NewsonNovember 5, 2025 Godrej Agrovet Q2 & H1 FY26 Results – Increased Revenue and ESG Focus Godrej Agrovet has announced its financial results for Q2 & H1 FY26. The company reported an 8% increase in revenue for H1 FY26, reaching…
Company Update2 Min Read InvestyWise NewsonNovember 5, 2025 Piramal Pharma Reports Q2 and H1 FY26 Results, Impacted by CDMO Destocking Piramal Pharma Limited announced its Q2 and H1 FY26 results, reporting a revenue decrease. Q2 FY26 revenue stood at ₹2,044 crores, a 9% YoY…
Company Update2 Min Read InvestyWise NewsonNovember 5, 2025 Piramal Pharma Reports Q2 and H1 FY26 Results, Impacted by CDMO Destocking Piramal Pharma Limited announced its Q2 and H1 FY26 results, reporting revenue of ₹2,044 crore for Q2 and ₹3,977 crore for H1. Revenue was…
Company Results2 Min Read InvestyWise NewsonNovember 5, 2025 Piramal Pharma Unaudited Results Reflect $179.3 Million Loss in Q2 2025 Piramal Pharma Limited announced its unaudited standalone and consolidated financial results for Q2 2025. The company reported a consolidated…
Board Meeting2 Min Read InvestyWise NewsonNovember 5, 2025 Syngene Board Approves Unaudited Financial Results for Q2 2026 Syngene International’s Board of Directors has approved the unaudited financial results for Q2 2026. Consolidated revenue reached ₹9,106…